BACKGROUND: Interferon-λs (IFN-λs) are novel cytokines with multiple functions, like IFN-α and -β. We examined possible anti-tumour effects produced by adenoviruses bearing the IFN-λ1 or -λ2 gene (Ad/IFN-λ) with the type-35 fibre-knob structure. METHODS: Proliferation of oesophageal carcinoma cells transduced with Ad/IFN-λ and mechanisms of the inhibited growth were investigated. RESULTS: Transduction with Ad/IFN-λ upregulated the expression of the class I antigens of the major histocompatibility complexes and induced the growth suppression. Increased sub-G1 populations and the cleavage of caspase-3 and poly (ADP-ribose) polymerase were detected in IFN-λ-sensitive YES-2 and T.Tn cells. The cell death was accompanied by cytoplasmic cytochrome C and increased cleaved caspase-9 and Bax expression, suggesting mitochondria-mediated apoptosis. Adenovirus/IFN-λ-infected YES-2 cells subsequently reduced the tumourigenicity. Adenovirus/IFN-λ-infected fibroblasts, negative for the IFN-λ receptors, induced death of YES-2 or T.Tn cells that were co-cultured. Inoculation of YES-2 cells in nude mice, when mixed with the Ad/IFN-λ-infected fibroblasts, resulted in retardation of the tumour growth. The growth suppression was not linked with upregulated CD69 expression on natural killer cells or increased numbers of CD31-positive cells. CONCLUSION: Adenovirus/IFN-λ induced apoptosis, and fibroblast-mediated delivery of IFN-λs is a potential cancer treatment by inducing direct cell death of the target carcinoma.
BACKGROUND: Interferon-λs (IFN-λs) are novel cytokines with multiple functions, like IFN-α and -β. We examined possible anti-tumour effects produced by adenoviruses bearing the IFN-λ1 or -λ2 gene (Ad/IFN-λ) with the type-35 fibre-knob structure. METHODS: Proliferation of oesophageal carcinoma cells transduced with Ad/IFN-λ and mechanisms of the inhibited growth were investigated. RESULTS: Transduction with Ad/IFN-λ upregulated the expression of the class I antigens of the major histocompatibility complexes and induced the growth suppression. Increased sub-G1 populations and the cleavage of caspase-3 and poly (ADP-ribose) polymerase were detected in IFN-λ-sensitive YES-2 and T.Tn cells. The cell death was accompanied by cytoplasmic cytochrome C and increased cleaved caspase-9 and Bax expression, suggesting mitochondria-mediated apoptosis. Adenovirus/IFN-λ-infected YES-2 cells subsequently reduced the tumourigenicity. Adenovirus/IFN-λ-infected fibroblasts, negative for the IFN-λ receptors, induced death of YES-2 or T.Tn cells that were co-cultured. Inoculation of YES-2 cells in nude mice, when mixed with the Ad/IFN-λ-infected fibroblasts, resulted in retardation of the tumour growth. The growth suppression was not linked with upregulated CD69 expression on natural killer cells or increased numbers of CD31-positive cells. CONCLUSION:Adenovirus/IFN-λ induced apoptosis, and fibroblast-mediated delivery of IFN-λs is a potential cancer treatment by inducing direct cell death of the target carcinoma.
Authors: Giovanni Vitale; Wouter W de Herder; Peter M van Koetsveld; Marlijn Waaijers; Wenda Schoordijk; Ed Croze; Annamaria Colao; Steven W J Lamberts; Leo J Hofland Journal: Cancer Res Date: 2006-01-01 Impact factor: 12.701
Authors: Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Joachim Diebold; Helmut Diepolder; Barbara Adler; Christoph J Auernhammer; Burkhard Göke; Julia Dambacher Journal: Am J Physiol Gastrointest Liver Physiol Date: 2005-07-28 Impact factor: 4.052
Authors: Tobias Marcello; Arash Grakoui; Giovanna Barba-Spaeth; Erica S Machlin; Sergei V Kotenko; Margaret R MacDonald; Charles M Rice Journal: Gastroenterology Date: 2006-10-01 Impact factor: 22.682
Authors: Ahmed Lasfar; Anita Lewis-Antes; Sergey V Smirnov; Shubha Anantha; Walid Abushahba; Bin Tian; Kenneth Reuhl; Harold Dickensheets; Faruk Sheikh; Raymond P Donnelly; Elizabeth Raveche; Sergei V Kotenko Journal: Cancer Res Date: 2006-04-15 Impact factor: 12.701
Authors: Kathrin Zitzmann; Stephan Brand; Sebastian Baehs; Burkhard Göke; Jennifer Meinecke; Gerald Spöttl; Heinrich Meyer; Christoph J Auernhammer Journal: Biochem Biophys Res Commun Date: 2006-04-24 Impact factor: 3.575
Authors: K Hasegawa; M Tagawa; K Takagi; H Tsukamoto; Y Tomioka; T Suzuki; Y Nishioka; T Ohrui; M Numasaki Journal: Cancer Gene Ther Date: 2016-08-19 Impact factor: 5.854